Thermogenesis Holdings Inc
F:THR
Thermogenesis Holdings Inc
F:THR
Price:
1.62
EUR
Market Closed
Market Cap:
€4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Thermogenesis Holdings Inc
F:THR
|
US |
|
Elisa Oyj
OTC:ELMUY
|
FI |
|
PubMatic Inc
NASDAQ:PUBM
|
US |
|
C
|
China Regenerative Medicine International Ltd
HKEX:8592
|
HK |
|
A
|
Aveanna Healthcare Holdings Inc
NASDAQ:AVAH
|
US |
|
S
|
SM Core Inc
KOSDAQ:007820
|
KR |
|
Gudang Garam Tbk PT
IDX:GGRM
|
ID |
|
T
|
Tiande Chemical Holdings Ltd
HKEX:609
|
HK |
|
B
|
Benchmark Bankshares Inc
OTC:BMBN
|
US |
|
Indiamart Intermesh Ltd
NSE:INDIAMART
|
IN |
|
T
|
TQM Alpha PCL
SET:TQM
|
TH |
|
Grand T G Gold Holdings Ltd
HKEX:8299
|
HK |
|
S
|
Sikri Group ASA
OSE:SIKRI
|
NO |
|
F
|
Firebird Metals Ltd
ASX:FRB
|
AU |
|
Cisco Systems Inc
NASDAQ:CSCO
|
US |
|
ClearStream Energy Services Inc
TSX:CSM
|
CA |
|
Maider Medical Industry Equipment Co Ltd
SSE:688310
|
CN |
|
F
|
Ferrocarril del Pacifico SA
SGO:FEPASA
|
CL |
|
V
|
VerticalScope Holdings Inc
TSX:FORA
|
CA |
Relative Value
There is not enough data to reliably calculate the relative value of THR.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
THR
Relative Value
Base Case
Not Available
Multiples Across Competitors
THR Competitors Multiples
Thermogenesis Holdings Inc Competitors
Thermogenesis Holdings Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Thermogenesis Holdings Inc
F:THR
|
4m EUR | 0.5 | -0.3 | -1.6 | -1.3 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
182B USD | 4.1 | 27.9 | 16 | 22 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
166.9B USD | 16.6 | 58.4 | 44.3 | 54.4 | |
| US |
|
Stryker Corp
NYSE:SYK
|
125.7B USD | 5 | 38.6 | 19.8 | 23.9 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
112.8B USD | 3.2 | 24.5 | 13.5 | 19.7 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
103.5B USD | 5.2 | 35.7 | 21 | 28.2 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
41.4B EUR | 1.8 | 19.7 | 11.1 | 15.6 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
48B USD | 7.9 | 44.8 | 24.6 | 27 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
45.9B USD | 10.7 | 43.3 | 30.7 | 34 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
45.1B USD | 2.1 | 25.7 | 10.1 | 17.1 | |
| US |
|
Resmed Inc
NYSE:RMD
|
33B USD | 6.1 | 22.2 | 15.6 | 17.3 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
